This article is for those wishing to better understand the GVAX vaccine and what has been learned from the failed Phase III trials under Cell Genesys and how it being used differently today. This explains why the GVAX hold was lifted and the direction it is headed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.